AstraZeneca (AZN) Follows Boehringer, to Cap Inhaler Cost in US

Mar 19, 2024 · AstraZeneca (AZN) plans to lower the prices of its inhaled respiratory products to $35 per month in the United States. However, the company intends to start this in June 2024.

CouponFollow Extension

$35
OFF

AstraZeneca (AZN) Follows Boehringer, To Cap Inhaler Cost In US

3 days from now

Mar 19, 2024 · AstraZeneca (AZN) plans to lower the prices of its inhaled respiratory products to $35 per month in the United States. However, the company intends to start this in June 2024.

yahoo.com

$35
OFF

AstraZeneca (AZN) Follows Boehringer, To Cap Inhaler Cost In US

3 days from now

Mar 19, 2024 · AstraZeneca AZN announced plans to cap out-of-pocket expenses for its inhaled respiratory portfolio in the United States at $35 ... Follows Boehringer, to Cap Inhaler Cost in …

nasdaq.com

$35
OFF

Following Boehringer's Lead, AstraZeneca ⁠caps Monthly Out-of …

3 days from now

Mar 18, 2024 · Following Boehringer's lead, AstraZeneca ⁠caps monthly out-of-pocket inhaler costs at $35 in the US By Fraiser Kansteiner Mar 18, 2024 11:02am AstraZeneca Symbicort …

fiercepharma.com

$35
OFF

AstraZeneca Follows Rival Boehringer In Capping Out-of-pocket …

3 days from now

March 18 (Reuters) – Drugmaker AstraZeneca (AZN.L) said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States, following a …

pharmalive.com

$35
OFF

AstraZeneca Follows Boehringer Ingelheim In Capping Inhaler Costs

3 days from now

Mar 18, 2024 · AstraZeneca will join Boehringer Ingelheim in capping out-of-pocket costs for its inhaler products at $35 per month, the company announced Monday (March 18). The move …

insidehealthpolicy.com

$35
OFF

AstraZeneca Follows Rival, Will Cap Inhaler Prices At $35 Per ... - MSN

3 days from now

“If AstraZeneca and Boehringer Ingelheim can cap the cost of inhalers at $35 in the United States, these other companies can do the same,” Sanders said. ... AstraZeneca follows rival, will cap ...

msn.com

$35
OFF

AstraZeneca Follows Rival, Will Cap Inhaler Prices At $35 Per ... - MSN

3 days from now

(The Hill) — Drugmaker AstraZeneca will cap out-of-pocket costs at $35 for all its inhaler products, the company announced Monday. The cap is effective June 1 and will apply to the …

msn.com

$35
OFF

AstraZeneca To Cap Out-of-pocket Inhaler Costs In US, Following …

3 days from now

Mar 18, 2024 · (Reuters) -Drugmaker AstraZeneca (NASDAQ: AZN) said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States …

investing.com

$35
OFF

AstraZeneca To Cap Costs Of Inhalers At $35 Per Month - MSN

3 days from now

AstraZeneca (NASDAQ:AZN) plans to cap out-of-pocket costs for its inhaler medications at $35 per month following Congressional criticism of the company's pricing of the products in the US. …

msn.com

$35
OFF

AstraZeneca To Cap Out-of-pocket Inhaler Costs In US ... - SaltWire

3 days from now

(Reuters) -Drugmaker AstraZeneca said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States ...

saltwire.com

$35
OFF

AstraZeneca To Cap Out-of-pocket Inhaler Costs In US, Following …

3 days from now

Mar 18, 2024 · Drugmaker AstraZeneca AZN said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States from June, following a …

tradingview.com

$35
OFF

AstraZeneca (AZN) Follows Boehringer, To Cap Inhaler Cost In US

3 days from now

AstraZeneca (AZN) announced plans to cap out-of-pocket expenses for its inhaled respiratory portfolio in the United States at $35 per month, following a similar move by rival Boehringer …

reportify.cc

FAQs about AstraZeneca (AZN) Follows Boehringer, to Cap Inhaler Cost in US Coupon?

Will AstraZeneca AZN cap out-of-pocket expenses?

AstraZeneca AZN announced plans to cap out-of-pocket expenses for its inhaled respiratory portfolio in the United States at $35 per month, following a similar move by rival Boehringer Ingelheim earlier this month. ...

How much does AstraZeneca AZN cost per month?

A wealth of resources for individual investors is available at www.zacks.com. AstraZeneca AZN announced plans to cap out-of-pocket expenses for its inhaled respiratory portfolio in the United States at $35 per month, following a similar move by rival Boehringer Ingelheim earlier this month. ...

Does AstraZeneca have a cap on inhalers?

This cap would apply to all of AstraZeneca’s inhaled respiratory products, which include Airsupra, Bevespi Aerosphere, Breztri Aerosphere and Symbicort. However, the company plans not to start this until June 2024. The British drugmaker is one of the biggest sellers of inhalers in the United States. ...

Are Boehringer & AstraZeneca inhalers cheaper?

One of the biggest manufacturers of inhalers in the United States, Boehringer’s inhaled respiratory portfolio includes Atrovent, Combivent, Spiriva, Stiolto and Striverdi. AstraZeneca and Boehringer’s aggressive price cuts come amid pressure to cut costs of asthma inhalers to make them affordable for American citizens. ...

Can AstraZeneca and Boehringer Ingelheim cap the cost of inhalers?

“If AstraZeneca and Boehringer Ingelheim can cap the cost of inhalers at $35 in the United States, these other companies can do the same,” Sanders said. Copyright 2022 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. ...

What happened to AstraZeneca?

Shares of AstraZeneca have lost 2.2% year to date against the industry’s 13.2% rise. Earlier this month, privately-held Boehringer Ingelheim said it would cap out-of-pocket expenses for all its inhaler products at $35 per month beginning in June. ...